Renata Ltd., a listed pharmaceutical and chemical company, is adding two drugs to the UK market. This information is known from Dhaka Stock Exchange (DSE) sources.
According to sources, the first shipment of Sertraline 100 mg and Propylthiouracil 50 mg tablets has been successfully dispatched to the UK market.
These high-quality products are manufactured at Reneta’s UK-MHRA approved facility in Rajendrapur, Bangladesh.
These medicines will soon reach UK consumers under the Renata-UK branding and in partnership with a local commercialization team.
In Bangladesh these drugs are known by their local brands Seronex (sertraline) and PTU (propylthiouracil).
